Flightpath Biosciences, Inc.
PrivateLast Round
Series A
Oct 23, 2024
Est. Valuation
$19M
Total Funding Raised
$8.25M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Flightpath Biosciences, Inc. is a biotechnology company that develops precision therapeutics targeting bacterial pathogens to treat infection-associated complex diseases while sparing the microbiome.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Flightpath Biosciences, Inc. Comparables
Compare Flightpath Biosciences, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Tonix Pharmaceuticals Holding Corp. | 55% | |
| Tarsus Pharmaceuticals | 54% | |
| Moderna | 52% | |
Flightpath Biosciences, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 23, 2024 | ||||
| Seed | Mar 8, 2023 | ||||
| Accelerator | Feb 9, 2021 |
Flightpath Biosciences, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Steven & Alexandra Cohen Foundation | Series A |
| Ann Arbor SPARK | Series A |
| Northern Michigan Angels | Series A |
| Michigan Rise | Series A, Seed |
| Michigan Strategic Fund | Seed |
| ID Ventures | Series A |
| Bay Area Lyme Foundation | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 76% MoM.
- Oct 23, 2024
$8M round with participation from Steven & Alexandra Cohen Foundation.
Flightpath Biosciences, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Flightpath Biosciences, Inc.'s valuation, stock price, and market status.